Advertisement LeMaitre Vascular releases new stent graft delivery system - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

LeMaitre Vascular releases new stent graft delivery system

LeMaitre Vascular has announced the commercial launch of the Tortuous Tracker Delivery System, the next-generation introducer for LeMaitre Vascular's EndoFit and UniFit Aortic stent graft product lines which will go on sale in the EU and other select markets outside of the US.

The Tortuous Tracker Delivery System (TT) is designed to simplify stent graft implants by requiring reduced deployment force, providing the physician with increased control over placement of the stent graft in the aorta. The company claims that the TT system offers better flexibility and an improved coating to increase maneuverability through blood vessels and a three-part valve system to minimize blood loss during the medical procedure. The TT system also provides better visualization during the procedure and a more ergonomic design.

The TT system will be available in a limited range of sizes initially and all sizes are expected to become available by the end of 2008.

George LeMaitre, chairman and CEO of LeMaitre Vascular, said: “We are pleased to be able to offer a delivery system that we believe meets the high performance standards set by our stent graft products. We believe that the prior generation delivery system had discouraged adoption of our stent grafts. The TT system removes this impediment to growth.”